accountleading pharmaceutical lawyers, professors, regulators, payers, and industry officials speculated on how impending federal guidelines might affect manufacturing and marketing of copycat medications made from living organisms.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to International Conference on Critical Issues of 'Biosimilars' Hosted by School of Pharmacy
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account